Syncytiotrophoblast-derived Extracellular Vesicles in Placenta Previa and Accreta Spectrum

ConditionsPlacenta Previa Placenta Accreta Spectrum

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexFemale

Age18+

SponsorFondazione Policlinico Universitario Agostino Gemelli IRCCS

About this trial

The main goal of this case-control study is to quantify the levels of circulating syncytiotrophoblast-derived extracellular vesicles (STBEVs) in maternal blood in a population of women with placenta previa and placenta accreta spectrum.

Eligibility criteria

Qualifiers

Pregnant women with diagnosis of placenta previa and accreta spectrum (cases)

Healthy pregnant women

> 18 years

Disqualifiers

< 18 years

Twin pregnancies

Chronic Infections

Cancers

Trial design

Treatments tested in this trial

Blood sample

Treatment groups

70 Participants

are divided into 1 treatment group

Sponsors and collaborators

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Lead sponsor

Source ClinicalTrials.gov